Cost-effectiveness and Down syndrome.

Nuchal translucency and first trimester biochemical markers for Down syndrome screening: a cost-effectiveness analysis

Nuchal translucency and first trimester biochemical markers for Down syndrome screening: a cost-effectiveness analysis

Nuchal translucency and first trimester biochemical markers for down syndrome screening: a cost-effectiveness analysis.

OBJECTIVE The purpose of this study was to perform a cost-effectiveness analysis that compared the first- and second- trimester screening tools for Down syndrome. STUDY DESIGN A decision tree was designed that compared four possible screens for Down syndrome: (1) current second- trimester expanded maternal serum alpha-fetoprotein test (AFP), (2) first-trimester nuchal translucency screen, (3)...

Nuchal translucency and first trimester biochemical markers for Down syndrome screening: a cost-effectiveness analysis

Nuchal translucency and first trimester biochemical markers for Down syndrome screening: a cost-effectiveness analysis